2015 Mar 4;35(9):3938-3945. Epub 2015 Mar 4.
Abstract
The Fmr1 knock-out mouse model of fragile X syndrome (Fmr1-/y) has an epileptogenic phenotype that is triggered by group I metabotropic glutamate receptor (mGluR) activation. We found that a membrane-permeable peptide that disrupts mGluR5 interactions with long-form Homers enhanced mGluR-induced epileptiform burst firing in wild-type (WT) animals, replicating the early stages of hyperexcitability in Fmr1-/y. The peptide enhanced mGluR-evoked endocannabinoid (eCB)-mediated suppression of inhibitory synapses, decreased it at excitatory synapses in WTs, but had no effect on eCB actions in Fmr1-/y. At a low concentration, the mGluR agonist did not generate eCBs at excitatory synapses but nevertheless induced burst firing in both Fmr1-/y and peptide-treated WT slices. This burst firing was suppressed by a cannabinoid receptor antagonist. We suggest that integrity of Homer scaffolds is essential for normal mGluR-eCB functioning and that aberrant eCB signaling resulting from disturbances of this molecular structure contributes to the epileptic phenotype of Fmr1-/y.
Copyright © 2015 the authors 0270-6474/15/353938-08$15.00/0.
Copyright © 2015 the authors 0270-6474/15/353938-08$15.00/0.
KEYWORDS:
DHPG; Fmr1; epilepsy; hippocampus; inhibitory synapses; seizure
- PMID:
- 25740522
- [PubMed – as supplied by publisher]